CompletedNot Applicable

An Online Cognitive Assessment in Cancer Patients

United States31 participantsStarted 2019-12-18

Plain-language summary

The purpose of this study is to test the feasibility (acceptability and usability) and usefulness of the CAMPFIRE (Cognitive Assessment and Monitoring Platform for Integrative Research) system, a patient-facing portal able to collect and produce reports for clinicians on Patient Reported Outcome Measurement Information System (PROMIS-Cognitive Function/Anxiety/Depression) outcomes via MyChart and NIH Toolbox, an inperson brief objective cognitive function battery. This study will aim to determine the value of the CAMPFIRE system for patients and providers as a tool for monitoring cognitive symptoms throughout the course of chemotherapy

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Must have diagnosis of cancer * Must be scheduled to receive any standard course of curative intent cytotoxic chemotherapy * Must have a computer, a general knowledge of how to use a computer and access to the internet * Must be able to speak and read English * Must be 21 years or older * Must provide informed consent Exclusion Criteria: * Must not be currently hospitalized or have been hospitalized for any psychiatric illness within the last year * Must not be diagnosed with neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease) * Must not have any CNS disease (e.g., movement disorder, multiple sclerosis)

What they're measuring

Completion

Timeframe: Post-Chemotherapy (16-18 weeks)

Trial details

NCT IDNCT04667689

SponsorUniversity of Rochester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-16

View on ClinicalTrials.gov More Cancer-Related Cognitive Difficulties trials